Tyler Harvey
Associate Director, Liver Biology, Nonclinical Development @Prime Medicine, Inc.
Signup · Get unlimited contacts
WORK HISTORY
Associate Director, Liver Biology, Nonclinical Development @Prime Medicine, Inc.
Cambridge, MA, US
Led biology efforts for the AATD program from early concept through IND-enabling execution- Helped shape program strategy by identifying key biological questions, prioritizing experiments, and aligning cross-functional stakeholders- Drive cross-functional program execution across biology, nonclinical, regulatory, and development teams- Contributed to key regulatory materials and content, including Type B pre-IND, Type D, IND Modules 2 and 4, and Health Canada pre-CTA documentation, to support major health authority interactions and submission milestones- Built and led a high-performing team of PhD scientists to advance liver-directed gene editing programs.Contributed to intellectual property generation as a named inventor- Manage and mentor a team of PhD scientists, supporting scientific excellence and program delivery- Named inventor on patent filings related to program and platform innovations.
EDUCATION
Marquette University
Bachelor's degree, Biology/Biological Sciences, General
The Johns Hopkins University
Doctor of Philosophy - PhD, Developmental Biology and Embryology
ABOUT TYLER HARVEY
I am a biology leader in gene editing and nonclinical development with deep experience advancing therapeutic programs from early research through IND-enabling studies. At Prime Medicine, I lead liver biology strategy within Nonclinical Development, building and advancing programs with a focus on translational rigor, cross-functional execution, and therapeutic impact.My work sits at the intersection of disease biology, gene editing, and program leadership. I have helped drive programs from inception through key regulatory milestones, including support for Type B pre-IND and Type D interactions, IND submissions, and Health Canada pre-CTA activities. I enjoy translating complex biological questions into clear development paths and aligning cross-functional teams around decisive experiments and program strategy.I have experience leading scientists, shaping nonclinical plans, contributing to regulatory documentation, and partnering across research, development, regulatory, and technical teams to move programs forward. I am also a patent inventor and am motivated by building therapies that can make a meaningful difference for patients.Core areas of focus include gene editing, liver biology, nonclinical development, translational biology, regulatory strategy support, and cross-functional leadership.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.